Deciding to start HIV treatment—and figuring out which drugs to start with—can be a daunting decision to make. Learning about the pros and cons of your various treatment options is your best weapon in the fight against HIV. The following information will help you communicate effectively with your doctor as you discuss your treatment choices.
Why is treatment necessary?
If HIV is allowed to reproduce, or “replicate,” inside the body, it will cause damage to the immune system. Ultimately, the immune system gets so weak that the body becomes vulnerable to other diseases. This is the point at which a person is usually diagnosed with AIDS, and the other diseases they get can eventually cause death. Without treatment, the average time between becoming infected with HIV and the development of AIDS is 10 years in the United States.
Research shows that people who who start HIV treatment early have a normal life expectancy. Not only does immediately going on HIV treatment help keep viral load low and CD4 cell counts high—therefore minimizing the risk of immune suppression and AIDS-related health complications—but it can minimize the risks of certain non-AIDS-related illnesses that are more common in people living with HIV. These include cardiovascular disease, kidney disease, liver disease and certain cancers.
HIV treatment is now recommended for all people living with HIV in the United States.
When should treatment be started?
The U.S. Department of Health and Human Services (DHHS)—the federal agency responsible for setting health-related policies in the United States—regularly updates and publishes HIV treatment guidelines to help people living with HIV and their health care providers determine when antiretroviral therapy should be started. Here is what the guidelines recommend:
- Antiretroviral therapy is recommended for all people with HIV to reduce morbidity and mortality and to prevent the transmission of HIV to others.
- Antiretroviral therapy should be initiated immediately (or as soon as possible) after a person is diagnosed to increase the uptake of antiretrovirals and linkage to care, decrease an individual’s time to viral suppression, and improve the rate of virologic suppression among people with HIV.
- It’s important to educate individuals diagnosed with HIV on the benefits and risks regarding antiretroviral therapy and deploy strategies to optimize care engagement and treatment adherence.
Here’s a look at the some benefits of starting treatment early, along with the possible risks of starting late:
Potential Benefits of Starting Early
- Keep your CD4 count high and possibly prevent irreversible damage to the immune system.
- Decrease your risk of certain HIV-related health problems that can sometimes occur in people with low CD4 counts, including tuberculosis, non-Hodgkin’s lymphoma, Kaposi’s sarcoma, peripheral neuropathy, cancers and pre-cancers caused by human papillomavirus (HPV), and mental deficits seen in some people with HIV, such as difficulty thinking and reasoning (neurocognitive problems).
- Decrease your risk of serious health problems that occur more frequently in people living with HIV, such as cardiovascular disease, kidney disease, liver disease, neurological complications and various non-AIDS-related cancers and infections.
- Reduce or eliminate your risk of transmitting HIV to others—several studies have confirmed that having an undetectable viral load reduces the risk of transmitting the virus to effectively zero, notably during sexual activity and pregnancy. Click here for more info about treatment as prevention.
- Risk of severely weakened immune system, which may be hard to restore.
- Risk of developing AIDS-related illnesses.
- Risk of transmitting HIV to others, including sexual partners and your child, if you become pregnant
What if I’m pregnant?
It is recommended that all pregnant women take HIV medications to protect their own health and also prevent mother-to-child transmission of HIV. Click here for detailed information about pregnancy and HIV.
How do I know my treatment is working?
When antiretroviral treatment is started, the level of HIV (viral load) should start to drop dramatically. During the first two months of therapy, a person’s viral load should drop a minimum of 90 percent. Within 4 to 6 months of starting therapy, the viral load should have hopefully dropped below the level of the viral load test’s sensitivity (“undetectable”). Most tests used today can detect as few as 20.
Your CD4 cell count will likely increase between 100 and 200 cells in the first 12 to 18 months, and can gradually climb from there as long as viral load remains undetectable. Some people who start HIV treatment for the first time have a poor CD4 response despite achieving and maintaining an undetectable viral load. Researchers refer to individuals in this situation as “discordant responders.” Most discordant responders waited to start treatment until their CD4 counts were well below 200. This is one of the reasons that the guidelines recommend starting ARVs immediately after diagnosis.
You and your doctor should continue monitoring your viral load on a regular basis to make sure that the HIV drugs are working properly and that the amount of virus in the blood remains below the level of detection or as low as possible.
If your viral load increases while taking HIV drugs, this may mean that drug resistance has occurred. Click here to learn more about drug resistance.
You should also have your CD4 cell count checked at least once a year. Additional tests that your health care provider should monitor to ensure that you are not experiencing certain side effects include proteins associated with liver and kidney health, your cholesterol and your blood sugar.
And be sure to discuss with your doctor any problems you are having with your treatment regimen without delay. If you find yourself missing doses or experiencing side effects, you might be able to switch your current regimen for one that is easier to take or associated with fewer side effects. But it is crucial that you do this sooner rather than later.
Last Reviewed: January 5, 2023